Overview
- 44 inspections across 43 sites are on record.
- 32 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-09-29.
At a glance
Inspections
44
Sites
43
Observations
32
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ritsa Pharma Private Limited | 29 Sep 2023 | Human Drugs | |
| Alivira Animal Health Limited | 22 Sep 2023 | Human Drugs | On file |
| Smilax Laboratories Limited | 15 Sep 2023 | Human Drugs | On file |
| Novo Nordisk Pharmaceutical Industries LP | 10 Feb 2022 | Human Drugs | |
| Signa S.A. de C.V. | 8 Sep 2017 | Human Drugs | On file |
Sites inspected
Ritsa Pharma Private LimitedMedchal, India1 insp.
Alivira Animal Health LimitedVisakhapatnam, India1 insp.
Smilax Laboratories LimitedParawada- Vishakapatnam District, India1 insp.
Novo Nordisk Pharmaceutical Industries LPClayton, United States1 insp.
Signa S.A. de C.V.Toluca De Lerdo, Mexico1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Luis A Carrion's 32 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site